JAPAN HAS approved a second drug – the inexpensive steroid dexamethasone - for the treatment of Covid-19 patients following the use of Remdesivir, reports said.
Showing posts with label Remdesivir. Show all posts
Showing posts with label Remdesivir. Show all posts
Friday, July 24, 2020
Friday, February 14, 2020
Gilead’s Remdesivir Begins Trials as Researchers Publish Positive In Vitro Results
CLINICAL TRIALS of Gilead Sciences’ remdesivir have begun in Wuhan, China, the center of the novel coronavirus outbreak, a day after Chinese researchers recommended that the antiviral drug candidate remdesivir be assessed in humans as a potential treatment for 2019-nCoV.
China’s National Medical Products Administration has approved applications by the China-Japan Friendship Hospital and the Chinese Academy of Medical Sciences to conduct trials evaluating remdesivir.
China’s National Medical Products Administration has approved applications by the China-Japan Friendship Hospital and the Chinese Academy of Medical Sciences to conduct trials evaluating remdesivir.
Subscribe to:
Posts (Atom)





